Nuvation Bio NUVB Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss?
- Nuvation Bio (NUVB) reported debt securities, available-for-sale, unrealized loss position, accumulated loss of $21K in Q4 2025.
- How has Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss changed year-over-year?
- Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss decreased by 96.3% year-over-year, from $560K to $21K.
- What is the long-term trend for Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss?
- Over 4 years (2021 to 2025), Nuvation Bio's debt securities, available-for-sale, unrealized loss position, accumulated loss has grown at a -66.7% compound annual growth rate (CAGR), from $1.71M to $21K.